Cutaneous Adverse Effects of Surface-Targeted Monoclonal Antibodies

Biologic therapies, such as surface-targeted monoclonal antibodies, have revolutionized medicine and offer targeted therapy for an increasing number of diseases; however, along with these advances and their ensuing expanded use have come many unique adverse effects. In this article, dermatologists review how to manage these adverse effects and when to consult a dermatologist.